Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.760
-0.080 (-2.08%)
At close: Feb 11, 2026, 4:00 PM EST
3.860
+0.100 (2.66%)
Pre-market: Feb 12, 2026, 6:26 AM EST

Organogenesis Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4774025373521,189962
Market Cap Growth
6.61%-25.09%52.51%-70.37%23.61%92.71%
Enterprise Value
4544165643751,2051,040
Last Close Price
3.763.204.092.699.247.53
PE Ratio
--108.6122.6712.6255.80
Forward PE
17.9058.18136.3311.9623.39-
PS Ratio
1.030.841.240.782.542.84
PB Ratio
1.871.041.931.334.936.78
P/TBV Ratio
2.211.822.301.636.3611.67
P/FCF Ratio
-96.3481.96-38.65-
P/OCF Ratio
-28.3217.3714.1719.18175.92
PEG Ratio
-0.410.410.41--
EV/Sales Ratio
0.980.861.300.832.583.07
EV/EBITDA Ratio
23.2310.7817.8010.6214.4029.12
EV/EBIT Ratio
330.3719.3234.5515.2516.5237.78
EV/FCF Ratio
-99.5386.05-39.17-
Debt / Equity Ratio
0.110.110.440.480.560.60
Debt / EBITDA Ratio
1.050.752.422.391.382.37
Debt / FCF Ratio
-10.3718.57-4.43-
Asset Turnover
0.971.010.951.011.271.32
Inventory Turnover
3.564.254.014.224.323.44
Quick Ratio
2.583.172.322.562.382.07
Current Ratio
3.323.692.802.972.742.56
Return on Equity (ROE)
0.30%0.26%1.82%6.13%49.17%17.46%
Return on Assets (ROA)
0.18%2.81%2.24%3.44%12.43%6.73%
Return on Invested Capital (ROIC)
0.40%7.31%2.66%6.80%35.94%22.42%
Return on Capital Employed (ROCE)
0.30%5.10%4.30%6.60%20.20%12.40%
Earnings Yield
-1.93%0.21%0.92%4.41%7.92%1.79%
FCF Yield
-10.82%1.04%1.22%-2.57%2.59%-1.27%
Buyback Yield / Dilution
3.51%0.81%-0.27%0.96%-20.03%-19.95%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q